ZOMETA 4 mg/100 ml, solution for infusion bottle, 100 ml
Active ingredients: Anhydrous zoledronic acid, Zoledronic acid monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusionbottle, 100 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZOMETA 4 mg/100 ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en plastique de 100 ml
- Marketing authorisation holder
- PHOENIX LABS (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 May 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66716961CIP72175264CIP133400921752649Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE ZOLÉDRONIQUE ANHYDREsolution | 4 mg · un flacon | FT |
| ACIDE ZOLÉDRONIQUE MONOHYDRATÉsolution | 4,264 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.